The estimated Net Worth of John M Capek is at least $60.9 Million dollars as of 13 December 2021. John Capek owns over 149,600 units of Abbott Laboratories stock worth over $54,918,367 and over the last 18 years he sold ABT stock worth over $2,229,574. In addition, he makes $3,765,920 as Executive Vice President - Ventures at Abbott Laboratories.
John has made over 12 trades of the Abbott Laboratories stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 149,600 units of ABT stock worth $5,227,024 on 13 December 2021.
The largest trade he's ever made was exercising 149,600 units of Abbott Laboratories stock on 13 December 2021 worth over $5,227,024. On average, John trades about 16,414 units every 73 days since 2007. As of 13 December 2021 he still owns at least 470,998 units of Abbott Laboratories stock.
You can see the complete history of John Capek stock trades at the bottom of the page.
Dr. John M. Capek Ph.D. serves as Executive Vice President - Ventures of the Company. was Executive Vice President - Ventures of the Company. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.
As the Executive Vice President - Ventures of Abbott Laboratories, the total compensation of John Capek at Abbott Laboratories is $3,765,920. There are 7 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $27,802,800.
John Capek is 58, he's been the Executive Vice President - Ventures of Abbott Laboratories since 2015. There are 21 older and 17 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
John's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez und Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: